Published in Law and Health Weekly, March 17th, 2007
For the fourth quarter 2006 consolidated revenues were $27.1 million, a 7% increase from $25.2 million reported in the fourth quarter of 2005. Gross margins on net product sales for quarters ended December 31, 2006 and 2005 were 48.7% and 45.7%, respectively. Operating income for the fourth quarter 2006 was $2.9 million compared with $4.4 million reported in the same quarter of the prior year. The Company noted the lower operating income resulted from increased expenses supporting development of its intranasal...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.